神经肿瘤反应评估标准在胶质瘤中的应用:常规与先进技术的实践方法
本文阐述神经肿瘤反应评估标准用于高级别和低级别胶质瘤治疗反应的影像学评估,讨论肿瘤进展、治疗反应、假性进展和假性反应的影像表现及实践要点,并说明常规MRI与灌注、弥散、波谱及氨基酸PET等先进技术的相关性。
要点
- 神经肿瘤反应评估标准是高级别胶质瘤治疗反应的客观影像评估工具。
- 术后、放疗和化疗后的影像判读需熟悉肿瘤生物学及各类治疗后的预期改变。
- 许多新发病灶为肿瘤细胞与放射性损伤组织的混合,需识别主要成分并按标准分类。
核心结论
- 放射科医生应识别病灶的主要成分并按神经肿瘤反应评估标准分类,以使患者获得最佳治疗。
研究设计与样本
- 本文为综述,讨论神经肿瘤反应评估标准在高级别和低级别胶质瘤中的实践应用,未报告检索范围与纳入文献数量。
关键影像表现/征象
- 讨论与肿瘤进展、肿瘤反应、假性进展和假性反应相关的影像表现。
- 评估胶质瘤患者时需关注放疗后48小时内成像的需求、放疗计划与等剂量曲线、T2/FLAIR高信号病灶的意义、放疗后评估时机的影响以及组织学标本中进展性疾病的定义。
- 许多新发病灶为肿瘤细胞与放射性损伤组织的混合,放射科医生需识别病灶的主要成分。
诊断标准与关键数值
- 按神经肿瘤反应评估标准对高级别和低级别胶质瘤的肿瘤进展、肿瘤反应、假性进展和假性反应进行分类。
临床应用与阅片要点
- 常规MRI表现需与灌注、弥散加权成像、波谱和氨基酸PET等先进技术结果相关联。
- 评估胶质瘤患者时需考虑放疗后48小时内成像的需求、放疗计划与等剂量曲线、T2/FLAIR高信号病灶的意义、放疗后评估时机的影响以及组织学标本中进展性疾病的定义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The Response Assessment in Neuro-Oncology criteria were developed as an objective tool for radiologic assessment of treatment response in high-grade gliomas. Imaging plays a critical role in the management of the patient with glioma, from initial diagnosis to posttreatment follow-up, which can be particularly challenging for radiologists. Interpreting findings after surgery, radiation, and chemotherapy requires profound knowledge about the tumor biology, as well as the peculiar changes expected to ensue as a consequence of each treatment technique. In this article, we discuss the imaging findings associated with tumor progression, tumor response, pseudoprogression, and pseudoresponse according to the Response Assessment in Neuro-Oncology criteria for high-grade and lower-grade gliomas. We describe relevant practical issues when evaluating patients with glioma, such as the need for imaging in the first 48 hours, the radiation therapy planning and isodose curves, the significance of T2/FLAIR hyperintense lesions, the impact of the timing for the evaluation after radiation therapy, and the definition of progressive disease on the histologic specimen. We also illustrate the correlation among the findings on conventional MR imaging with advanced techniques, such as perfusion, diffusion-weighted imaging, spectroscopy, and amino acid PET. Because many of the new lesions represent a mixture of tumor cells and tissue with radiation injury, the radiologist aims to identify the predominant component of the lesion and categorize the findings according to Response Assessment in Neuro-Oncology criteria so that the patient can receive the best treatment.
引用
- Leao DJ, Craig PG, Godoy LF, et al. Response Assessment in Neuro-Oncology Criteria for Gliomas: Practical Approach Using Conventional and Advanced Techniques. AJNR Am J Neuroradiol. 2019. PMID: 31857322. doi:10.3174/ajnr.A6358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。